More mileage out of myelin

A team led by U.K. researchers has shown that retinoid X receptor

agonists can enhance remyelination of demyelinated axons in rodents by increasing the differentiation of oligodendrocyte precursor cells into oligodendrocytes.¹ This remyelination activity could spark interest in repurposing the agonists, which are on the market and in the clinic for cancer...